Krishana Phoschem
- P/E
- 37.78
Key Fundamentals
MicrocapFertilizers & AgrochemicalsChemicalsPrice-based figures as of · EPS basis: Standalone · TTM
- ROCE
- 27.20%
- Debt to Equity
- 1.31
- EPS (TTM)
- ₹6.36
- Book Value
- ₹18.14
- Market Cap
- —
- P/E (TTM)
- 37.78
- P/B
- 13.25
- ROE
- 38.20%
- Dividend Yield
- 0.22%
- EBITDA
- ₹314 Cr
- 52W High
- ₹242.33
- 52W Low
- ₹90.86
- Day Range
- ₹229.81 – ₹242.33
- Volume
- 20,32,359
Peer Comparison
Commodities › Chemicals › Fertilizers
| ₹1,837.00 | 29.58 | ₹53,760 Cr | 4.32 | 0.61% | 16.40% | 22.00% | ₹32,602 Cr | ₹1,778 Cr | |
| ₹764.05 | — | ₹48,951 Cr | 36.61 | 0.03% | −2.94% | 4.02% | ₹5,934 Cr | −₹106 Cr | |
| ₹394.15 | 8.19 | ₹15,752 Cr | 1.52 | 1.31% | 20.00% | 25.20% | ₹20,123 Cr | ₹1,928 Cr | |
| ₹137.21 | 12.23 | ₹14,054 Cr | 1.99 | 1.12% | 16.20% | 15.40% | ₹23,447 Cr | ₹1,073 Cr | |
| ₹187.29 | 53.06 | ₹8,452 Cr | 10.11 | 0.27% | 31.30% | 19.30% | ₹1,874 Cr | ₹155 Cr | |
| ₹240.29 | 37.78 | ₹7,305 Cr | 13.25 | 0.22% | 38.20% | 27.20% | ₹2,555 Cr | ₹196 Cr | |
| ₹140.74 | 8.09 | ₹5,467 Cr | 0.43 | 3.67% | 5.51% | 7.16% | ₹12,344 Cr | ₹693 Cr | |
| Median 7 companies | ₹240.29 | 20.91 | ₹14,054 Cr | 4.32 | 0.61% | 16.40% | 19.30% | ₹12,344 Cr | ₹693 Cr |
Comparable companies in the same industry. Market cap, P/E and P/B use the latest price; other metrics are as reported in filings. A dash means the figure is not published for that company.
Tapetide Score
Data-driven rating, 0–100, as of . How it works →
Overall score
Data confidence 100/100
Category scores
- Quality
- 43
- Weak
- Returns, margins, earnings quality 22% weight
- Valuation
- 29
- Poor
- Cheap vs sector & own history 24% weight
- Growth
- 99
- Strong
- Sales & profit trajectory 9% weight
- Financial Health
- 40
- Weak
- Solvency, leverage, coverage 9% weight
- Momentum
- 99
- Strong
- Trend strength, vol-adjusted 12% weight
- Ownership
- 64
- Good
- FII/DII/promoter flows 24% weight
The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.
Key Insights
Strengths
4- Company is expected to give good quarter
- Company has delivered good profit growth of 55.9% CAGR over last 5 years
- Company has a good return on equity (ROE) track record: 3 Years ROE 28.0%
- Company's median sales growth is 33.6% of last 10 years
Weaknesses
2- Stock is trading at 10.7 times its book value
- Company might be capitalizing the interest cost
Technical Indicators
| Group | Signal | Bearish | Neutral | Bullish |
|---|---|---|---|---|
| Overall | Strong Bullish | 4 | 2 | 13 |
| Oscillators | Bearish | 4 | 2 | 3 |
| Moving Averages | Strong Bullish | 0 | 0 | 10 |
Oscillators
Bearish
Overall
Strong Bullish
Moving Averages
Strong Bullish
Key readings
- RSI (14)
- 74.71
- Bearish
- MACD (12,26,9)
- 11.36
- Bullish
- SMA (50)
- 196.67
- Bullish
- SMA (200)
- 144.95
- Bullish
As of
Growth Rate
From the financial statements below. 10Y, 5Y, 3Y: compound annual growth to Mar 2026; 1Y: fiscal year to Mar 2026 against Mar 2025; TTM: four quarters to Jun 2026 against Jun 2025.
Revenue
| 10Y | +39.11% |
|---|---|
| 5Y | +66.64% |
| 3Y | +95.57% |
| 1Y | +78.30% |
| TTM | +73.27% |
Net profit
| 10Y | +68.08% |
|---|---|
| 5Y | +55.18% |
| 3Y | +88.21% |
| 1Y | +106.90% |
| TTM | +92.16% |
Operating cash flow
| 10Y | Turned negative |
|---|---|
| 5Y | Turned negative |
| 3Y | Outflow widened by ₹158 Cr |
| 1Y | Turned negative |
| TTM | — |
TTM: Reported once a year, so there is no trailing-twelve-month figure.
Operating margin· change in pp
| 10Y | −1.15 pp |
|---|---|
| 5Y | −8.41 pp |
| 3Y | −3.77 pp |
| 1Y | −1.25 pp |
| TTM | −1.41 pp |
Revenue by year
| Mar 2017 | ₹80.00 Cr |
|---|---|
| Mar 2018 | ₹96.00 Cr |
| Mar 2019 | ₹146 Cr |
| Mar 2020 | ₹162 Cr |
| Mar 2021 | ₹188 Cr |
| Mar 2022 | ₹318 Cr |
| Mar 2023 | ₹323 Cr |
| Mar 2024 | ₹923 Cr |
| Mar 2025 | ₹1,355 Cr |
| Mar 2026 | ₹2,416 Cr |
Net profit by year
| Mar 2017 | ₹3.00 Cr |
|---|---|
| Mar 2018 | ₹4.00 Cr |
| Mar 2019 | ₹14.00 Cr |
| Mar 2020 | ₹14.00 Cr |
| Mar 2021 | ₹20.00 Cr |
| Mar 2022 | ₹29.00 Cr |
| Mar 2023 | ₹27.00 Cr |
| Mar 2024 | ₹40.00 Cr |
| Mar 2025 | ₹87.00 Cr |
| Mar 2026 | ₹180 Cr |
AI Analysis — Bull vs Bear
Krishana Phoschem Ltd is a chemicals company with a market cap of ₹5,609 Cr trading at a P/E of 28.3x and P/B of 9.93x. The company has delivered exceptional profit growth of 95% TTM and 89% CAGR over 3 years, with ROE expanding to 38% in the last year, though its valuation multiples are elevated relative to book value.
- TTM compounded profit growth of 95% demonstrates strong earnings momentum
- 3-year compounded profit CAGR of 89% shows sustained high growth trajectory
- Last year ROE of 38% is significantly above the 3-year average of 28%, indicating improving capital efficiency
- TTM sales growth of 73% signals robust top-line expansion and strong demand
- 5-year compounded sales CAGR of 67% reflects consistent revenue scaling over a longer period
- 10-year median sales growth of 33.6% indicates a long track record of above-average organic growth
- Stock CAGR of 61% over 1 year and 60% over 3 years shows consistent investor re-rating alongside fundamentals
- 5-year profit CAGR of 55.9% well above typical chemical sector peers suggests structural competitive advantage
- P/E of 28.3x against a chemicals sector context demands continued high earnings delivery to justify valuation
- Potential capitalisation of interest costs raises accounting quality concerns and may overstate reported profitability
- Dividend yield of just 0.28% offers negligible income cushion during any market correction
- Debt-to-equity data is unavailable, making it difficult to fully assess balance sheet risk and leverage
- Market cap of ₹5,609 Cr for a niche chemical company implies rich expectations that may be vulnerable to commodity price cycles
- 10-year ROE average of 20% vs last year's 38% suggests recent returns may be cyclically inflated rather than structurally permanent
- 52-week high and low data unavailable, limiting visibility on recent price volatility and drawdown risk
This is AI-generated analysis, not financial advice. Do your own due diligence.
AI News Digest
TL;DR: Recent newsflow for Krishana Phoschem is entirely procedural with no material positive or negative catalysts. The upcoming 5:1 stock split may improve retail liquidity, and zero promoter encumbrance signals clean promoter holding. No operational or financial updates have emerged, so the near-term outlook depends on upcoming quarterly results and commodity price trends in the phosphate/chemical space.
- Stock split record date July 3 Jun 24
Krishana Phoschem set July 3, 2026 as record date for a 5:1 stock split, converting each Rs 10 share into five Rs 2 shares.
- New independent director appointed Jun 24
Archana Dangi regularised as Non-Executive Independent Director for a five-year term ending May 25, 2031.
- No promoter shares encumbered Jun 17
Krishana Phoschem disclosed zero promoter share encumbrance as of March 31, 2026, filed with NSE.
Quarterly Results
₹ Cr| Particulars | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 165 | 265 | 230 | 263 | 281 | 301 | 304 | 473 | 396 | 608 | 659 | 755 | 532 |
| Expenses | 133 | 218 | 207 | 238 | 239 | 260 | 260 | 417 | 330 | 535 | 589 | 666 | 443 |
| Operating Profit | 32 | 47 | 24 | 26 | 42 | 40 | 44 | 56 | 66 | 73 | 70 | 89 | 89 |
| OPM % | 20% | 18% | 10% | 10% | 15% | 13% | 15% | 12% | 17% | 12% | 11% | 12% | 17% |
| Other Income | 1 | −1 | 0 | 1 | 1 | 2 | 2 | 6 | 3 | 3 | 4 | 5 | 6 |
| Interest | 7 | 10 | 9 | 11 | 12 | 10 | 9 | 8 | 9 | 7 | 9 | 14 | 21 |
| Depreciation | 8 | 8 | 9 | 8 | 8 | 8 | 8 | 8 | 8 | 9 | 9 | 9 | 14 |
| PBT | 18 | 28 | 6 | 7 | 23 | 25 | 29 | 47 | 51 | 61 | 57 | 72 | 61 |
| Tax % | 33% | 32% | 41% | 17% | 28% | 32% | 29% | 30% | 40% | 45% | 41% | −15% | 22% |
| Net Profit | 12 | 19 | 4 | 6 | 16 | 17 | 21 | 33 | 31 | 33 | 33 | 83 | 47 |
| EPS (₹) | 0.4 | 0.62 | 0.12 | 0.18 | 0.53 | 0.54 | 0.66 | 1.06 | 0.99 | 1.07 | 1.08 | 2.69 | 1.52 |
Profit & Loss
₹ Cr| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 73 | 89 | 80 | 96 | 146 | 162 | 188 | 318 | 323 | 923 | 1,355 | 2,416 | 2,555 |
| Expenses | 63 | 77 | 64 | 77 | 112 | 127 | 149 | 263 | 271 | 795 | 1,171 | 2,118 | 2,233 |
| Operating Profit | 10 | 12 | 15 | 19 | 33 | 35 | 39 | 56 | 52 | 128 | 184 | 298 | 322 |
| OPM % | 13% | 13% | 19% | 20% | 23% | 22% | 21% | 17% | 16% | 14% | 14% | 12% | 13% |
| Other Income | 4 | 2 | 1 | 1 | 0 | 0 | 2 | 1 | 3 | 2 | 10 | 16 | 19 |
| Interest | 5 | 5 | 4 | 6 | 3 | 3 | 2 | 4 | 7 | 37 | 39 | 39 | 50 |
| Depreciation | 3 | 6 | 6 | 8 | 11 | 12 | 10 | 10 | 9 | 34 | 31 | 34 | 40 |
| PBT | 5 | 3 | 6 | 6 | 19 | 21 | 28 | 43 | 39 | 59 | 123 | 241 | 250 |
| Tax % | 43% | 54% | 46% | 44% | 29% | 34% | 31% | 31% | 31% | 32% | 30% | 25% | — |
| Net Profit | 3 | 1 | 3 | 4 | 14 | 14 | 20 | 29 | 27 | 40 | 87 | 180 | 197 |
| EPS (₹) | 0.14 | 0.07 | 0.13 | 0.14 | 0.54 | 0.55 | 0.75 | 0.99 | 0.9 | 1.31 | 2.8 | 5.83 | 6.36 |
| Div. Payout % | 0% | 0% | 0% | 0% | 0% | 9% | 7% | 5% | 6% | 8% | 4% | 2% | — |
Balance Sheet
₹ Cr| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 21 | 21 | 25 | 25 | 25 | 25 | 26 | 30 | 31 | 62 | 62 | 62 |
| Reserves | 52 | 59 | 68 | 71 | 85 | 100 | 121 | 191 | 231 | 239 | 322 | 499 |
| Borrowings | 30 | 32 | 46 | 42 | 32 | 12 | 21 | 70 | 276 | 436 | 376 | 733 |
| Other Liabilities | 19 | 5 | 14 | 11 | 29 | 21 | 27 | 39 | 44 | 108 | 276 | 347 |
| Total Liabilities | 122 | 117 | 152 | 149 | 170 | 158 | 195 | 330 | 582 | 845 | 1,036 | 1,641 |
| Fixed Assets | 72 | 72 | 80 | 112 | 106 | 96 | 94 | 85 | 358 | 322 | 295 | 450 |
| CWIP | 9 | 8 | 25 | 0 | 1 | 0 | 7 | 92 | 3 | 43 | 78 | 1 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 42 | 37 | 48 | 37 | 64 | 62 | 94 | 153 | 220 | 479 | 664 | 1,189 |
| Total Assets | 122 | 117 | 152 | 149 | 170 | 158 | 195 | 330 | 582 | 845 | 1,036 | 1,641 |
Cash Flow
₹ Cr| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | 10 | 8 | 14 | 25 | 18 | 23 | 10 | −5 | −33 | −83 | 154 | −191 |
| Investing | −11 | −3 | −31 | −15 | −5 | −1 | −19 | −84 | −190 | −37 | −32 | −116 |
| Financing | 1 | −5 | 17 | −9 | −13 | −21 | 9 | 89 | 223 | 121 | −110 | 316 |
| Net Cash Flow | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 12 | 9 |
| Free Cash Flow | −1 | 4 | −16 | 9 | 13 | 21 | −12 | −91 | −226 | −121 | 116 | −305 |
| CFO/OP | 116 | 72 | 105 | 138 | 68 | 77 | 43 | 17 | −51 | −57 | 95 | −50 |
Ratios
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 24 | 62 | 66 | 52 | 53 | 41 | 54 | 60 | 84 | 104 | 102 | 108 |
| Inventory Days | 290 | 97 | 224 | 127 | 157 | 135 | 145 | 103 | 194 | 84 | 60 | 65 |
| Days Payable | 115 | 20 | 94 | 43 | 85 | 22 | 41 | 39 | 16 | 35 | 67 | 47 |
| Cash Conversion Cycle | 200 | 139 | 195 | 136 | 126 | 154 | 158 | 124 | 263 | 154 | 95 | 126 |
| Working Capital Days | 36 | 49 | 57 | 22 | 52 | 87 | 95 | 95 | 64 | 44 | 42 | 40 |
| ROCE % | 11% | 7% | 8% | 9% | 16% | 17% | 20% | 20% | 11% | 15% | 22% | 27% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Krishana Phoschem insights
57 extracted metrics across FY15–FY27.
Documents
- Q1 FY27 concall · Jul 2026Transcript PPT Recording
- Q4 FY26 concall · Apr 2026Transcript Recording
- Q3 FY26 concall · Jan 2026Transcript PPT Recording
- Q2 FY26 concall · Oct 2025Transcript PPT Recording
- 13 Jul 2026
- 26 May 2026
- 26 May 2026
- 8 Apr 2026
- 8 Apr 2026
- 6 Oct 2026
- 8 Jul 2026
- 9 Apr 2026
- 31 Mar 2026
- 17 Feb 2026
- Certificate under sebi (depositories and participa 8 Oct 2026
- Analysts/institutional investor meet/con. call upd 30 Sep 2026
- Analysts/institutional investor meet/con. call upd 22 Sep 2026
Frequently Asked Questions about Krishana Phoschem
What does Krishana Phoschem Ltd do?
Where is Krishana Phoschem Ltd (KRISHANA) listed?
Which sector does Krishana Phoschem Ltd belong to?
What is the PE ratio of Krishana Phoschem Ltd?
What is the 52-week high and low of Krishana Phoschem Ltd?
Does Krishana Phoschem Ltd pay dividends?
What is the Return on Equity (ROE) of Krishana Phoschem Ltd?
Company Information
Incorporated in 2004, Krishana Phoschem Ltd is in the business of manufacturing fertilisers & chemicals. It manufactures and markets fertilisers under the brands ‘Annadata’ (SSP) and ‘Bharat’ (NPK/DAP complex).
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/KRISHANA.md for Krishana Phoschem Ltd: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.
Append .md to any Tapetide URL for
the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For
live, structured queries instead of documents, use our Indian stock market MCP server.